280. Huge arteriovenous malformation with cervicofacial or limb lesion
22 clinical trials, 26 drugs (DrugBank: 13 drugs), 11 drug target genes, 147 drug target pathways
Searched query = "Huge arteriovenous malformation with cervicofacial or limb lesion", "Huge arteriovenous malformation", "Arteriovenous malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00243893 (ClinicalTrials.gov) | July 2004 | 24/10/2005 | Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms | Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms | Aneurysms;Arteriovenous Malformations | Drug: minocycline;Drug: doxycycline | University of California, San Francisco | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | 13 Years | 80 Years | Both | 26 | Phase 1 | United States |